Day: December 13, 2021

SAN FRANCISCO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Shift (Nasdaq: SFT), a leading end-to-end auto ecommerce platform transforming the used car industry with a technology-driven, hassle-free customer experience, announced a $100 million committed floorplan facility with Ally Financial Inc. (NYSE:ALLY), a leading digital financial services company. The new floorplan financing relationship expands the companies’ business relationship and has a two-year term, expiring December 9, 2023. “Our business is rapidly scaling, with 2021 sales expected to more than triple compared to 2020. As a result, our financing needs have grown as well,” said Oded Shein, Shift’s CFO. “This new facility improves Shift’s capital position, doubling the availability of our previous floor plan, and increases our financial flexibility as we look to accelerate future...

Norwegian Breakaway and Norwegian Getaway’s Hybrid Exhaust Gas Cleaning Systems Commissioned Nearly Two Years Ahead of Schedule Approximately 70% of Company’s Operational Capacity Now Equipped with Innovative EGCS Technology MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the ”Company”), a leading global cruise company which operates Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises, today announced the successful completion of its nearly $200 million, multi-year investment in exhaust gas cleaning systems (“EGCS”) on certain ships across its fleet with the successful commissioning of EGCS onboard Norwegian Breakaway and Norwegian Getaway. The new systems are aimed at improving the ships’ environmental footprint by significantly reducing emissions, including sulfur oxides...

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc.(NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation advertising, announced today announced that the Company has hired TraDigital IR, a leading financial and digital media communications firm, to assist with its investor relations program. Dean Julia, CEO of Mobiquity Technologies, commented, “We are pleased to appoint TraDigital as our investor relations advisor. TraDigital’s industry expertise and capital markets knowledge will assist Mobiquity in its efforts to strengthen our communication with investors and improve market awareness of our Company. We look forward to working closely with TraDigital to convey our business story, growth strategy, competitive advantages, and value proposition to the investment community.”   “Our...

Data Presented in Poster Presentation at American Society of Hematology Annual Meeting BURLINGAME, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating the potential of CPI-818, the company’s ITK inhibitor, for the prevention and therapy of acute graft versus host disease (aGVHD) in patients receiving allogeneic hematopoietic cell transplantation (bone marrow transplantation). The data will be presented today in a poster at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition. Bone marrow transplantation is a potentially curative therapy for patients with a variety of blood disorders, including blood cancers, certain solid cancers, hemoglobinopathies such as sickle cell disease,...

BRISBANE, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, announced safety and dose-response data from its Phase 1 clinical trial of ANX009, the company’s subcutaneously administered product candidate that is designed to block the activity of C1q and the entire classical complement pathway. In addition, Annexon reported preclinical data supporting the role of the complement pathway in warm autoimmune hemolytic anemia (wAIHA). The data were presented during two poster sessions at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition. “We are pleased to present these data at ASH, which further...

95% overall response rate, 65% complete response rate and favorable safety profile in patients treated with modified cell manufacturing process Data presented at the 63rd American Society of Hematology (ASH) Annual Meeting Key opinion leader conference call on Thursday, December 16, 2021, at 2:30 p.m. EST WORCESTER, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced updated data from the ongoing Phase 1/2 clinical trial of MB-106, a CD20-targeted, autologous CAR T cell therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphomas (“B-NHLs”) and chronic lymphocytic...

SANTA CLARA, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) —  AMD (NASDAQ: AMD) today announced that AMD President and CEO Dr. Lisa Su will host its 2022 Product Premiere on January 4, 2022. Dr. Su will highlight innovations and solutions featuring upcoming AMD Ryzen™ processors and AMD Radeon™ graphics. The AMD Product Premiere livestream will be accessible to the public beginning at 10 a.m. EST on Tuesday, January 4 at AMD.com; replays will be available after the conclusion of the livestream event. Supporting Resources:Visit the AMD 2022 Product Premiere landing page Follow AMD on Twitter and LinkedIn Become a fan of AMD on FacebookAbout AMDFor 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds...

Telehealth Innovator Launches into Public Markets VANCOUVER, British Columbia, Dec. 13, 2021 (GLOBE NEWSWIRE) — UniDoc Health Corp. (CSE: UDOC) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce its common shares will commence trading on the Canadian Securities Exchange (“CSE”) at the opening of the market on December 13, 2021, under the ticker symbol “UDOC.” Additional information is now available on the Company website at www.unidoctor.com. UniDoc is a virtual health/telehealth solutions company. The Company’s primary offering will be the Virtual Care Solutions Model, a proprietary, customizable, and comprehensive telehealth solution that integrates a range of physical products, web-based services, and analytical tools, along with access to the Company’s developing network of healthcare...

GBT601 demonstrated average hemoglobin occupancy of greater than 30% with 100 mg daily doses in a multiple ascending dose study of six adult SCD patients GBT601 tolerability was favorable in studies of SCD patients and healthy volunteers   Study results provide proof of concept to support the continued development of GBT601 GBT to host investor conference call and webcast today at 12:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced new data from a Phase 1 study of GBT021601 (GBT601), the company’s investigational next-generation sickle hemoglobin (HbS) polymerization inhibitor, that demonstrated average hemoglobin (Hb) occupancy greater than 30% and improvements in hematologic parameters in a cohort of six patients with sickle cell disease...